About Yokota Maternity Hospital
Clinical Trials at Yokota Maternity Hospital
During the past decade, Yokota Maternity Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Yokota Maternity Hospital
According to Clinical.Site data, the most researched conditions in "Yokota Maternity Hospital" are
"Cervical Ripening" (1 trials) and "Infertility" (1 trials). Many other conditions were trialed in "Yokota Maternity Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Yokota Maternity Hospital
Most popular intervention types in "Yokota Maternity Hospital" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Dinoprostone" (1 trials), "Follitropin beta" (1 trials) and "Follitropin delta" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Yokota Maternity Hospital
The vast majority of trials in "Yokota Maternity Hospital" are
2 trials for "Female" genders.
Clinical Trials Status at Yokota Maternity Hospital
Currently, there are NaN active trials in "Yokota Maternity Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Yokota Maternity Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Yokota Maternity Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".